Skip to main content
AAPL $255.76 +1.24% MSFT $401.86 -0.93% GOOGL $303.55 -1.35% AMZN $209.53 +0.47% NVDA $183.14 +1.43% TSLA $395.01 -0.83% META $638.18 -1.32% JPM $282.89 -1.32% V $306.50 +0.00% WMT $125.33 +0.95% AAPL $255.76 +1.24% MSFT $401.86 -0.93% GOOGL $303.55 -1.35% AMZN $209.53 +0.47% NVDA $183.14 +1.43% TSLA $395.01 -0.83% META $638.18 -1.32% JPM $282.89 -1.32% V $306.50 +0.00% WMT $125.33 +0.95%

NASDAQ: TECH

Bio-Techne Corporation

Healthcare • Biotechnology • www.bio-techne.com

$51.47 $-2.15 (-4.01%)

Data as of Mar 13, 1:02 PM UTC

Key Statistics

Market Cap $9.45B
P/E Ratio 120.15
Dividend Yield 0.01%
Volume 3,710,349
Avg Volume 2,208,757
52-Week High $72.16
52-Week Low $46.01

About Bio-Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Analyst Ratings

View All →
Buy Based on 23 analysts
Avg Price Target $69.67 (+35.4% upside)
Date Firm Rating
Nov 20, 2025 Argus Research Buy
Nov 6, 2025 Wells Fargo Overweight
Nov 6, 2025 UBS Buy
Oct 14, 2025 TD Cowen Buy
Oct 7, 2025 Evercore ISI Group Outperform

Related Stocks

TECH FAQ

What is Bio-Techne Corporation's stock price today?

Bio-Techne Corporation (NASDAQ:TECH) stock is trading at $51.47 as of the latest market data.

Does Bio-Techne Corporation pay a dividend?

Yes, Bio-Techne Corporation pays a dividend with a current yield of 0.53%.

What do analysts think about Bio-Techne Corporation stock?

Wall Street analysts have a consensus Buy rating on Bio-Techne Corporation (TECH).